Sugar Nanoparticles Beat Brain Cancer in Mice

A significant advancement in the fight against glioblastoma, a particularly aggressive form of brain cancer, has been reported by researchers. They have engineered sugar-coated nanoparticles designed to overcome the challenges of delivering therapeutic agents across the blood-brain barrier.

These innovative nanoparticles utilize a sugar called mannose, which shares a transport mechanism with glucose, allowing them to pass the blood-brain barrier. The key innovation lies in densely coating the nanoparticles with mannose, enabling them to compete effectively for transport into the brain. Once inside, the nanoparticles preferentially accumulate in glioblastoma tumors, which exhibit higher levels of sugar transporters.

Experiments conducted on mice demonstrated a remarkable 9.9-fold increase in nanoparticle delivery to the brain compared to uncoated versions. The sugar-coated particles then deliver messenger RNA (mRNA) to cancer cells, instructing them to produce the PTEN protein, which helps control cell growth. This targeted therapy resulted in a significant reduction in tumor size, from 52% of brain occupancy in untreated mice to just 2.3% in treated mice over 28 days.

Beyond shrinking tumors, the treatment also extended median survival time in the treated mice from 33 to 49 days. Importantly, no measurable organ toxicity was observed. While these findings are from mouse models and further research is required for human application, the strategy's efficiency and the potential to apply it to other neurological disorders are highly encouraging. The research was published in the Journal of Controlled Release.